Research | Published:

Improved Bivalent Miniantibodies, with Identical Avidity as Whole Antibodies, Produced by High Cell Density Fermentation of Escherichia coli

Nature Biotechnology volume 11, pages 12711277 (1993) | Download Citation

Subjects

Abstract

The combination of single-chain Fv-fragments (scFv) with a C-terminal, flexible linking region followed by a designed or natural dimerization domain provides a versatile system for targeted association of functional fragments in the periplasmic space of Escherichia coli. For homodimerization in vivo, two scFv fragments with a C-terminal hinge followed by a helix-turn-helix motif form “miniantibodies” with significantly higher avidity than in the case of leucine zipper containing constructs. The favorable design probably results in an antiparallel four-helix bundle and brings the homodimer to the same avidity as the whole IgA antibody, from which the binding site was taken. The molecular weight of the bivalent miniantibody is almost the same as that of a monovalent Fab fragment. We report here a high-cell density fermentation of E. coli producing these miniantibodies and a work-up procedure suitable for large scale production. Without any need of subsequent chemical coupling in vitro, approximately 200 mg/l of functional dimeric miniantibodies can be directly obtained from the E. coli culture.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    and 1992. Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric Fv fragments with high avidity in Escherichia coli . Biochemistry 31: 1579–1584.

  2. 2.

    and 1972. The influence of polyvalency on the binding properties of antibodies. Immunochemistry 9: 341–357.

  3. 3.

    1978. The affinity of antibody: range, variability, and the role of multivalence, pp. 85–116. In: Immunoglobulins. Litman, G. W. and Good, R. A. (Eds.). Plenum Publishing Corp., NY and London.

  4. 4.

    , , and 1990. A comparison of strategies to stabilize immunoglobulin Fv-fragments. Biochemistry 29: 1362–1367.

  5. 5.

    , , , , , , , , and 1988. Single-chain antigen-binding proteins. Science 242: 423–426.

  6. 6.

    , , , , , , , , , and 1988. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli . Proc. Natl. Acad. Sci. USA 85: 5879–5883.

  7. 7.

    , , and 1991. X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil. Science 254: 539–545.

  8. 8.

    , and 1989. Evidence that the leucine zipper is a coiled coil. Science 243: 538–542.

  9. 9.

    , , , , and 1986. The design, synthesis, and crystallization of an alpha-helical peptide. Proteins 1: 16–22.

  10. 10.

    and 1987. Design of a 4-helix bundle protein: synthesis of peptides which self-associate into a helical protein. J. Am. Chem. Soc. 109: 6751–6758.

  11. 11.

    , and 1992. The disulfide bonds in antibody variable domains: effects on stability, folding in vitro, and functional expression in Escherichia coli . Biochemistry 31: 1270–1279.

  12. 12.

    , , and 1986. Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7Å. J. Mol. Biol. 190: 593–604.

  13. 13.

    and 1988. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli . Science 240: 1038–1041.

  14. 14.

    and 1989. Expression of functional Fv and Fab fragments in Escherichia coli . Meth. Enzymol. 178: 497–515.

  15. 15.

    , , and 1992. Mono- and bivalent antibody fragments produced in E. coli : binding properties and folding in vivo , pp. 10–13. In: ACS Conference Proceedings Series, Harnessing Biotechnology for the 21st Century. Ladisch, M. R. and Bose, A. (Eds.) ACS, Washington, DC.

  16. 16.

    and 1993. A versatile and highly repressible E. coli expression system based on invertible promoters. Gene. In press

  17. 17.

    1991. High-cell-density cultivation of Escherichia coli . Current Opinion in Biotechnol. 2: 380–384.

  18. 18.

    , , , and 1971. Modification of immunoglobulin combining sites, pp. 253–267. In: Progress in immunology: Proceedings of the 1st Congress of Immunology. Amos, B. (Ed.). Academic Press, New York.

  19. 19.

    and 1991. Engineering the quaternary structure of an exported protein with a leucine zipper. Prot. Engineering 4: 457–461.

  20. 20.

    , , and 1990. Sequence requirements for coiled coils: analysis with λ-repressor-GCN4 leucine zipper fusions. Science 250: 1400–1403.

  21. 21.

    , and 1992. Formation of a bispecific antibody by the use of leucine zippers. J. Immunol. 148: 1547–1553.

  22. 22.

    , , , , , and 1989. Effect of dose, molecular size, affinity, and protein uptake of antibody or ligand: a biomathematical model. Cancer Res. 49: 3290–3296.

  23. 23.

    , , , , , , and 1993. Medical applications of single-chain antibodies. Intern. Rev. of Immunol. In press

  24. 24.

    , and 1980. Gene regulation at the right operator (O R) of bacteriophage λ-O R3 and autogenous negative control by represser. J. Mol. Biol. 139: 147–161.

  25. 25.

    , , , , , , , , , , , , and 1992. High level Escherichia coli expression and production of a bivalent humanized antibody fragment. Bio/Technology 10: 163–167.

  26. 26.

    , and 1989. Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.

  27. 27.

    , , , , , , and 1988. A short polypeptide marker sequence useful for recombinant protein identification and purification. Bio/Technology 6: 1204–1210.

  28. 28.

    , , , , , and 1990. High cell density fermentation of recombinant Escherichia coli expressing human interferon alpha 1. Appl. Microbiol. Biotechnol. 34: 77–82.

  29. 29.

    1990. Stabilitätsverhalten eines rekombinanten ColEl-Plasmid-derivates mit Ampicillin-Resistenzmarker und Human-Interferon-α-1-Gen in Escherichia coli . PhD-Thesis. Technical University Dresden, Fed. Rep. of Germany.

  30. 30.

    and 1992. Improved sequencing of “mini-prep” double-stranded templates using a multiwell microplate system. Biotechniques 13: 104–106.

  31. 31.

    1987. Chemical composition of Escherichia coli . 3–6. In: Escherichia and Salmonella typhimurium. Cellular and Molecular Biology. F. C. Neidhardt (Ed. in chief). ASM Washington, D.C.

  32. 32.

    , , and 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265–275.

  33. 33.

    1957. Spectrophotometric and turbidimetric methods for measuring proteins. Meth. Enzymol. 3: 447–454.

  34. 34.

    and 1989. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182: 319–326.

  35. 35.

    1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685.

  36. 36.

    1985. Immunoglobulin G: functional sites. Mol. Immunol. 22: 161–182.

  37. 37.

    , , , , and 1988. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J. 7: 1989–1994.

  38. 38.

    , and 1991. Predicting coiled coils from protein sequences. Science 252: 1162–1164.

  39. 39.

    , , , and 1993. Characterization of the linker peptide of the single-chain Fv fragment of an antibody by NMR spectroscopy. FEBS Lett. 320: 97–100.

  40. 40.

    , and 1987. Structure of the ColE1 Rop protein at 1.7Å resolution. J. Mol. Biol. 196: 657–675.

  41. 41.

    1991. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Cryst. 24: 946–950.

Download references

Author information

Author notes

    • Peter Pack

    Current Address: MorphoSys, Frankfurter Ring 193a, D-80807 München, Fed. Rep. Germany.

    • Andreas Plückthun

    Corresponding author. Address after October 1993: Biochemisches Institut, Universität Zürich, Winterthurerstr. 190, CH-8057 Zürich, Switzerland.

Affiliations

  1. Max-Planck-Institut für Biochemie, Protein Engineering Group, Am Klopferspitz, D-82152 Martinsried, Fed. Rep. Germany.

    • Andreas Plückthun
  2. Hans-Knöll-Institut für Naturstoff-Forschung, Beutenbergstr. 11, D-07745 Jena, Fed. Rep. Germany.

    • Marian Kujau
    • , Volker Schroeckh
    • , Uwe Knüpfer
    • , Rolf Wenderoth
    •  & Dieter Riesenberg

Authors

  1. Search for Peter Pack in:

  2. Search for Marian Kujau in:

  3. Search for Volker Schroeckh in:

  4. Search for Uwe Knüpfer in:

  5. Search for Rolf Wenderoth in:

  6. Search for Dieter Riesenberg in:

  7. Search for Andreas Plückthun in:

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nbt1193-1271

Further reading